Skip to main content
TELA
NASDAQ Industrial Applications And Services

TELA Bio Sets October 8 Vote on Reverse Split as Nasdaq Deadline Passes

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.04
Mkt Cap
$46.691M
52W Low
$0.501
52W High
$1.7
52W Position info
108% above low
Off High info
39% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

TELA has more than doubled off its 52-week low of $0.501.

Summary

TELA Bio's definitive proxy sets an October 8 special meeting to vote on a 1-for-5 to 1-for-15 reverse split, confirming the company missed its September 14 Nasdaq compliance deadline and now faces a Hearings Panel review.


Key Events · Corporate Governance and Compliance · TELA

  • Nasdaq Compliance Deadline Missed

    The September 14, 2026 deadline to regain the $1.00 minimum bid price passed without compliance. The stock closed at $0.83 on the record date.

  • Ineligible for Standard Extension

    TELA Bio cannot access the additional 180-day compliance period because it also fails Nasdaq's stockholders' equity requirement under Rule 5550(b)(1).

  • Hearings Panel Appeal Planned

    The company will request a Nasdaq Hearings Panel review to stay delisting, submit a compliance plan, and seek a continued listing exception.

  • Reverse Split Vote Set for October 8

    Shareholders vote on a 1-for-5 to 1-for-15 reverse split at a virtual special meeting. The board can implement any ratio within that range within one year of approval.


Analysis · TELA · Industrial Applications And Services

TELA Bio's definitive proxy confirms the company missed its September 14 Nasdaq compliance deadline and is now ineligible for the standard 180-day extension because it also fails the stockholders' equity requirement. The company must now convince a Nasdaq Hearings Panel to grant an exception, with the reverse split vote on October 8 as its primary compliance tool. Failure to win shareholder approval or panel acceptance would push the stock to OTC markets, where liquidity typically collapses for a company already trading at $0.83.

How filings like this one have moved

In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TELA was trading at $1.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $46.7M. The 52-week trading range was $0.50 to $1.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TELA - Latest Insights

TELA
Sep 04, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8215
Real-time Price: $1.22 info
Change: +$0.4012 (+49%) info
Market Cap: $53.269M info
TELA
Aug 31, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6611
Real-time Price: $1.22 info
Change: +$0.5616 (+85%) info
Market Cap: $53.269M info
TELA
Aug 11, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.790
Real-time Price: $1.22 info
Change: +$0.4327 (+55%) info
Market Cap: $53.269M info
TELA
Aug 10, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.930
Real-time Price: $1.22 info
Change: +$0.2927 (+31%) info
Market Cap: $53.269M info
TELA
Aug 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.9135
Real-time Price: $1.22 info
Change: +$0.3092 (+34%) info
Market Cap: $53.269M info